The factors helping the renewables industry plan for the future

Commitment from government

clock • 2 min read

Renewable energy accounted for more than 30% of the UK's electricity mix during the first quarter of 2018, a report published by the Department for Business, Energy, Industry & Industrial Strategy (BEIS) shows.

UK renewables capacity stood at a record 41.9GW at the end of March 2018, up 11.2% year-on-year. Much of this growth is the result of an increase in operational offshore wind capacity, which now stands at 7.4GW in the UK. A significant decline in the cost of generating power from offshore windfarms, which makes it more economical than new gas or nuclear power plants, has certainly provided the impetus for expansion. There is a further 7GW of capacity under construction or with contracts in place for development, which is enough to power 4.9 million homes. Hermes' Lundie on the drivers...

To continue reading this article...

Join Investment Week for free

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now

 

Already an Investment Week
member?

Login

More on Specialist

Deep Dive: Thematics offer diversification but investors must consider bond sensitivity

Deep Dive: Thematics offer diversification but investors must consider bond sensitivity

‘Dedicated specialists’

James Baxter-Derrington
clock 06 April 2023 • 4 min read
European private equity yet to spend €270bn worth of capital

European private equity yet to spend €270bn worth of capital

Deployment of capital expected

Kathleen Gallagher
clock 04 January 2023 • 1 min read
Early-stage biopharma: An opportunity for strategic investment

Early-stage biopharma: An opportunity for strategic investment

Disproportionately smaller investment

Ali H. Munawar
clock 10 August 2022 • 4 min read
Trustpilot